GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea · Delayed Price · Currency is KRW

5,090.00

-80.00 (-1.55%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Korea (Ansan)		38.40B	-	-	-	-
Korea (Gongju)		41.63B	-	-	-	-
Unallocated Adjustments		-554.31M	-	-	-	-
Total		79.48B	-	-	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Korea (Gongju)		-	41.84B	29.96B	24.69B	23.27B
Korea (Gongju) Growth		-	39.62%	21.37%	6.10%	4.94%
Korea (Ansan)		-	41.46B	33.48B	35.74B	31.26B
Korea (Ansan) Growth		-	23.84%	-6.32%	14.36%	-7.41%
Unallocated		-	-541.68M	-634.26M	-1.31B	-2.76B
United States		-	-	-	4.08B	6.48B
United States Growth		-	-	-	-37.10%	-30.70%
Total		-	82.76B	62.81B	63.19B	58.24B
Total Growth		-	31.75%	-0.60%	8.50%	-7.27%

Source: S&P Global Market Intelligence.